Drug information for CATAPRES-TTS-2
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
FILM, EXTENDED RELEASE; TRANSDERMAL
0.2MG/24HR
Prescription
AB
CLONIDINE
Clonidine
BOEHRINGER INGELHEIM
18891
2010-05-07 Label
2010-05-03 Letter
2010-01-07 Letter
2009-11-13 Label
2006-04-14 Letter
2004-08-25 Letter
2003-08-05 Review
Drug Adverse Effects information for CATAPRES-TTS-2
Role code
Indications
Reaction
# Reports
SS
ANAEMIA OF CHRONIC DISEASE
ALOPECIA
1
SS
ANAEMIA OF CHRONIC DISEASE
HAEMOGLOBIN DECREASED
1
C
CROHN'S DISEASE
BLOOD PRESSURE INCREASED
1
C
CROHN'S DISEASE
DIZZINESS
1
C
CROHN'S DISEASE
FEELING ABNORMAL
1
C
CROHN'S DISEASE
HEART RATE INCREASED
1
C
CROHN'S DISEASE
WRONG TECHNIQUE IN DRUG USAGE PROCESS
1
C
HEPATITIS C
ASTHENIA
2
C
HEPATITIS C
BLOOD GLUCOSE INCREASED
2
C
HEPATITIS C
CHILLS
2
C
HEPATITIS C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
2
C
HEPATITIS C
CONSTIPATION
2
C
HEPATITIS C
COUGH
2
C
HEPATITIS C
CREPITATIONS
2
C
HEPATITIS C
DECREASED APPETITE
2
C
HEPATITIS C
DEHYDRATION
2
C
HEPATITIS C
DIZZINESS
2
C
HEPATITIS C
DYSPNOEA
2
C
HEPATITIS C
GAIT DISTURBANCE
2
C
HEPATITIS C
NAUSEA
2
C
HEPATITIS C
PLATELET COUNT DECREASED
2
C
HEPATITIS C
PNEUMONIA
2
C
HEPATITIS C
RESPIRATORY DISTRESS
2
C
HEPATITIS C
VOMITING
2
Ads by Google